Tessera Therapeutics Appoints Joseph Romanelli as President and Chief Executive Officer
Go back to Tessera Therapeutics Appoints Joseph Romanelli as President and Chief Executive Officer| Merck & Co. (NYSE: MRK) | Delayed: 130.42 -0.5 (0.38%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $130.92 | 52 Week High | $65.46 | |||
| Open | $129.93 | 52 Week Low | $47.97 | |||
| Day High | $132.84 | P/E | 88.72 | |||
| Day Low | $129.70 | EPS | $1.47 | |||
| Volume | 6,343,840 | |||||
| Regeneron (NASDAQ: REGN) | Delayed: 797.00 -11.05 (1.37%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $808.05 | 52 Week High | $592.36 | |||
| Open | $808.80 | 52 Week Low | $325.35 | |||
| Day High | $813.63 | P/E | 209.19 | |||
| Day Low | $796.66 | EPS | $3.81 | |||
| Volume | 940,107 | |||||
